Diagnostic chain operator Thyrocare Technologies (NSE:THYROCARE, BOM:539871) has agreed to invest an additional $25,000 in its joint venture company Thyrocare Laboratories (Tanzania), according to a Monday filing to the Indian stock exchanges,
Following the investment and on the allotment of shares by the JV company, Thyrocare Laboratories (Tanzania) will become a subsidiary of the company.
The joint venture company provides diagnostic and healthcare services directly to customers in Tanzania.
Price (INR): ₹659.50, Change: ₹-3.6, Percent Change: -0.54%